Feiba 2,500 unit (nominal)s
Ended Awarded Last action
- Contract number
- SPE2DR26FQS2Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,142
Award facts
- Contract value 100% obligated
- $14,141.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,141.55 to AmerisourceBergen Drug Corp on December 16, 2025, for the delivery of 2,500 units of FEIBA (Factor Eight Inhibitor Bypassing Activity), a specialized pharmaceutical product used in hemophilia treatment. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution and fulfillment capabilities.
This delivery order falls under AmerisourceBergen's $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen fulfills critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, supplying brand-name and generic medications, vaccines, medical devices, and specialized therapeutics across multiple therapeutic domains. The company's demonstrated capacity to deliver specialized medical products such as FEIBA reflects its role as a primary vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQS2Q?
SPE2DR26FQS2Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FQS2Q worth?
The government has obligated $14,142 on SPE2DR26FQS2Q.
Is contract SPE2DR26FQS2Q an order under another contract?
Yes. SPE2DR26FQS2Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS2Q competed?
The extent of competition for SPE2DR26FQS2Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award